UDG Healthcare plc announced the appointment of Ms Anne Whitaker as a Non-Executive Director of the company with effect from 1 October 2020. In addition, in connection with the previously announced Chair succession, the company also announces changes to the composition of its Board Committees. Anne has more than 25 years of experience in the life science industry, including senior leadership roles with large pharmaceutical, biotech, and speciality pharma companies. She is currently the Chief Executive Officer of Aerami Therapeutics (formerly Dance Biopharm Holdings Inc.), a clinical stage pharmaceutical and medical device company, having held this role since October 2018. UDG announced that with effect from 1 October 2020, Shane Cooke assumes the role of Independent Non-Executive Chair of the company, succeeding Peter Gray who retired from the company on 30 September 2020. Also, with effect from 1 October 2020, Shane succeeds Peter as Chair of the Nominations, Governance and Sustainability Committee and also joins the Remuneration Committee.